Comments on: The “Naked” Truth About Antibodies For Cancer Therapy- Part II http://www.hammerstockblog.com/the-naked-truth-about-antibodies-for-cancer-therapy-part-ii/ Biotech stock reviews Sun, 14 Mar 2010 02:22:34 +0000 http://wordpress.org/?v=2.3.1 By: Ohad Hammer http://www.hammerstockblog.com/the-naked-truth-about-antibodies-for-cancer-therapy-part-ii/#comment-203 Ohad Hammer Sat, 17 May 2008 21:42:14 +0000 http://www.hammerstockblog.com/the-naked-truth-about-antibodies-for-cancer-therapy-part-ii/#comment-203 Thanks, CB. That's exactly what I would say, and judging by the emails I got in the past 24 hours, there are many scientists and investors who think the same. I hope to publish an article next week about the results published so far for ASCO by Immunogen, Seatlle Genetics and their partners. There is a potential for even better results presented for the phase I weekly T-DM1 trial during the conference itself. This dosing schedule will probably invovle higher overall doses and unlike the every 3-week trial, where patients spend 2 weeks out of 3 with no actual T-DM1 in their bloodstream, patients should have T-DM1 constantly flowing throughout the study. The abstracts have been submitted in December so I expect Genentech to present updated figures for higher doses and larger patient population. Best, Ohad Thanks, CB.

That’s exactly what I would say, and judging by the emails I got in the past 24 hours, there are many scientists and investors who think the same.

I hope to publish an article next week about the results published so far for ASCO by Immunogen, Seatlle Genetics and their partners.

There is a potential for even better results presented for the phase I weekly T-DM1 trial during the conference itself. This dosing schedule will probably invovle higher overall doses and unlike the every 3-week trial, where patients spend 2 weeks out of 3 with no actual T-DM1 in their bloodstream, patients should have T-DM1 constantly flowing throughout the study. The abstracts have been submitted in December so I expect Genentech to present updated figures for higher doses and larger patient population.

Best,
Ohad

]]> By: cornbread44 http://www.hammerstockblog.com/the-naked-truth-about-antibodies-for-cancer-therapy-part-ii/#comment-200 cornbread44 Fri, 16 May 2008 07:02:09 +0000 http://www.hammerstockblog.com/the-naked-truth-about-antibodies-for-cancer-therapy-part-ii/#comment-200 Dear Ohad big fan of your blog. I have been following companies such as SGEN and IMGN for some time now and I find your articles very informative. Wouldn't you say that the concept of armed antibodies is finally reaching maturity? Both SGEN and IMGN presented some very nice results at ASCO. Best, CB Dear Ohad

big fan of your blog. I have been following companies such as SGEN and IMGN for some time now and I find your articles very informative.

Wouldn’t you say that the concept of armed antibodies is finally reaching maturity? Both SGEN and IMGN presented some very nice results at ASCO.

Best,
CB

]]>